• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促炎型 CD14(+)CD16(+)单核细胞与慢性肾脏病透析前患者的血管僵硬有关。

Proinflammatory CD14(+)CD16(+) monocytes are associated with vascular stiffness in predialysis patients with chronic kidney disease.

机构信息

Division of Nephrology, Department of Internal Medicine, Korea University, Anam Hospital, Seoul, Korea.

出版信息

Kidney Res Clin Pract. 2013 Dec;32(4):147-52. doi: 10.1016/j.krcp.2013.08.001. Epub 2013 Sep 26.

DOI:10.1016/j.krcp.2013.08.001
PMID:26877933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4714098/
Abstract

BACKGROUND

Chronic inflammation is frequently noted in patients with chronic kidney disease (CKD) and contributes to the development and progression of cardiovascular diseases. Monocytes are heterogeneous populations of cells, and they can be divided into subtypes with different phenotypes and functions based on CD14 and CD16 positivity. This study examined whether the proinflammatory CD14(+)CD16(+) monocyte subset expands in predialysis CKD patients, and also whether the expansion of these cells is closely associated with systemic inflammation and cardiovascular risk factors.

METHODS

The percentages of proinflammatory CD14(+)CD16(+) monocytes were analyzed in 111 predialysis CKD patients using a flow cytometer, and they were compared with brachial-ankle pulse wave velocity as well as the cytokine plasma levels and other clinical parameters.

RESULTS

The proportion of CD14(+)CD16(+) monocytes was significantly higher in patients with advanced stages of CKD than in patients with the early stages. Interleukin-6 levels were also high in patients with advanced stages of CKD. The expansion of CD14(+)CD16(+) monocytes showed significant positive correlations with the high-sensitive C-reactive protein levels, and negative correlations with the levels of serum albumin, hemoglobin, and 25(OH)-vitamin D. In addition, the expansion of CD14(+)CD16(+) monocytes was an independent factor correlated with brachial-ankle pulse wave velocity in diabetic CKD patients.

CONCLUSION

Expansion of the proinflammatory CD14(+)CD16(+) monocyte subset partially accounts for chronic inflammation, malnutrition, and atherosclerosis in CKD.

摘要

背景

慢性肾脏病(CKD)患者常伴有慢性炎症,该炎症可促进心血管疾病的发生和发展。单核细胞是异质性细胞群体,根据 CD14 和 CD16 的阳性表达,可以将其分为具有不同表型和功能的亚型。本研究旨在探讨在未透析的 CKD 患者中,促炎型 CD14(+)CD16(+)单核细胞亚群是否会扩增,以及这些细胞的扩增是否与全身炎症和心血管危险因素密切相关。

方法

采用流式细胞术分析 111 例未透析的 CKD 患者促炎型 CD14(+)CD16(+)单核细胞的比例,并与肱踝脉搏波速度以及细胞因子的血浆水平和其他临床参数进行比较。

结果

与 CKD 早期患者相比,CKD 晚期患者的 CD14(+)CD16(+)单核细胞比例显著升高。晚期 CKD 患者的白细胞介素-6 水平也较高。CD14(+)CD16(+)单核细胞的扩增与高敏 C 反应蛋白水平呈显著正相关,与血清白蛋白、血红蛋白和 25(OH)-维生素 D 水平呈负相关。此外,在糖尿病 CKD 患者中,CD14(+)CD16(+)单核细胞的扩增是与肱踝脉搏波速度相关的独立因素。

结论

促炎型 CD14(+)CD16(+)单核细胞亚群的扩增部分解释了 CKD 患者的慢性炎症、营养不良和动脉粥样硬化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c212/4714098/61657440c9d1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c212/4714098/1cf5198b32da/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c212/4714098/06cd008accda/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c212/4714098/61657440c9d1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c212/4714098/1cf5198b32da/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c212/4714098/06cd008accda/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c212/4714098/61657440c9d1/gr3.jpg

相似文献

1
Proinflammatory CD14(+)CD16(+) monocytes are associated with vascular stiffness in predialysis patients with chronic kidney disease.促炎型 CD14(+)CD16(+)单核细胞与慢性肾脏病透析前患者的血管僵硬有关。
Kidney Res Clin Pract. 2013 Dec;32(4):147-52. doi: 10.1016/j.krcp.2013.08.001. Epub 2013 Sep 26.
2
Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease.载脂蛋白 A-I 水平降低和高密度脂蛋白胆固醇水平降低与中间型 CD14++CD16+单核细胞计数升高相关,后者可预测慢性肾脏病患者的心血管事件。
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2120-7. doi: 10.1161/ATVBAHA.114.304172. Epub 2014 Jul 24.
3
CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease.慢性肾脏病患者中 CD14++CD16+ 单核细胞与心血管结局。
Eur Heart J. 2011 Jan;32(1):84-92. doi: 10.1093/eurheartj/ehq371. Epub 2010 Oct 12.
4
Inflammation, Senescence and MicroRNAs in Chronic Kidney Disease.慢性肾脏病中的炎症、衰老与微小RNA
Front Cell Dev Biol. 2020 Aug 6;8:739. doi: 10.3389/fcell.2020.00739. eCollection 2020.
5
Immunosuppression and monocyte subsets.免疫抑制与单核细胞亚群
Nephrol Dial Transplant. 2015 Jan;30(1):143-53. doi: 10.1093/ndt/gfu315. Epub 2014 Oct 13.
6
CD14+CD16+ monocytes from chronic kidney disease patients exhibit increased adhesion ability to endothelial cells.慢性肾病患者的CD14+CD16+单核细胞对内皮细胞的黏附能力增强。
Contrib Nephrol. 2011;171:57-61. doi: 10.1159/000327134. Epub 2011 May 23.
7
Monocyte subpopulations and cardiovascular risk in chronic kidney disease.慢性肾脏病患者单核细胞亚群与心血管风险。
Nat Rev Nephrol. 2012 Mar 13;8(6):362-9. doi: 10.1038/nrneph.2012.41.
8
Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists.活动期类风湿关节炎患者单核细胞亚群上TLR2和TLR9的过表达有助于增强对TLR激动剂的反应性。
Arthritis Res Ther. 2016 Jan 13;18:10. doi: 10.1186/s13075-015-0901-1.
9
Chronic Kidney Disease-Associated Inflammation Increases the Risks of Acute Kidney Injury and Mortality after Cardiac Surgery.慢性肾脏病相关性炎症增加心脏手术后急性肾损伤和死亡的风险。
Int J Mol Sci. 2020 Dec 18;21(24):9689. doi: 10.3390/ijms21249689.
10
Adipose-derived mesenchymal stem cells modulate CD14CD16 expression on monocytes from sepsis patients in vitro via prostaglandin E2.脂肪来源的间充质干细胞通过前列腺素E2在体外调节脓毒症患者单核细胞上CD14CD16的表达。
Stem Cell Res Ther. 2017 Apr 26;8(1):97. doi: 10.1186/s13287-017-0546-x.

引用本文的文献

1
Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies.慢性肾脏病中的瓣膜钙化:近期临床和临床前研究的新见解
Clin Kidney J. 2025 Mar 13;18(Suppl 1):i27-i45. doi: 10.1093/ckj/sfae421. eCollection 2025 Mar.
2
Genetic association analysis of lipid-lowering drug target genes in chronic kidney disease.慢性肾脏病降脂药物靶基因的遗传关联分析
Front Endocrinol (Lausanne). 2025 Jan 14;15:1434145. doi: 10.3389/fendo.2024.1434145. eCollection 2024.
3
Prediction of outcome using CD14CD16, CD14CD16 and CD14CD16 monocyte subpopulations in patients with complicated intra-abdominal infections.

本文引用的文献

1
Monocyte subpopulations and cardiovascular risk in chronic kidney disease.慢性肾脏病患者单核细胞亚群与心血管风险。
Nat Rev Nephrol. 2012 Mar 13;8(6):362-9. doi: 10.1038/nrneph.2012.41.
2
Microinflammation in hemodialysis patients is associated with increased CD14CD16(+) pro-inflammatory monocytes: possible modification by on-line hemodiafiltration.血液透析患者的微炎症与 CD14CD16(+)促炎单核细胞增多有关:在线血液透析滤过可能对此有调节作用。
Blood Purif. 2011;31(4):281-8. doi: 10.1159/000321889. Epub 2011 Jan 14.
3
Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity.
应用 CD14CD16、CD14CD16 和 CD14CD16 单核细胞亚群预测复杂腹腔内感染患者的结局。
Med Microbiol Immunol. 2023 Oct;212(5):381-390. doi: 10.1007/s00430-023-00779-4. Epub 2023 Sep 8.
4
The effect of probiotic supplementation on systemic inflammation in dialysis patients.补充益生菌对透析患者全身炎症的影响。
Kidney Res Clin Pract. 2022 Jan;41(1):89-101. doi: 10.23876/j.krcp.21.014. Epub 2021 Nov 18.
5
Arterial Remodelling in Chronic Kidney Disease: Impact of Uraemic Toxins and New Pharmacological Approaches.慢性肾脏病中的动脉重塑:尿毒症毒素的影响及新的药理学方法
J Clin Med. 2021 Aug 25;10(17):3803. doi: 10.3390/jcm10173803.
6
Macrophage Heterogeneity in Kidney Injury and Fibrosis.巨噬细胞异质性在肾损伤和纤维化中的作用。
Front Immunol. 2021 May 20;12:681748. doi: 10.3389/fimmu.2021.681748. eCollection 2021.
7
Inflammation, Senescence and MicroRNAs in Chronic Kidney Disease.慢性肾脏病中的炎症、衰老与微小RNA
Front Cell Dev Biol. 2020 Aug 6;8:739. doi: 10.3389/fcell.2020.00739. eCollection 2020.
8
Association of CD14 with incident dementia and markers of brain aging and injury.CD14 与新发痴呆及脑老化和损伤标志物的相关性。
Neurology. 2020 Jan 21;94(3):e254-e266. doi: 10.1212/WNL.0000000000008682. Epub 2019 Dec 9.
9
New Insights into the Roles of Monocytes/Macrophages in Cardiovascular Calcification Associated with Chronic Kidney Disease.单核细胞/巨噬细胞在与慢性肾脏病相关的心血管钙化中作用的新见解
Toxins (Basel). 2019 Sep 12;11(9):529. doi: 10.3390/toxins11090529.
10
Correlations between Traditional and Nontraditional Indicators of Adiposity, Inflammation, and Monocyte Subtypes in Patients with Stable Coronary Artery Disease.稳定型冠状动脉疾病患者中肥胖、炎症及单核细胞亚群的传统与非传统指标之间的相关性
J Obes. 2019 Jul 3;2019:3139278. doi: 10.1155/2019/3139278. eCollection 2019.
衰老的 CD14+CD16+单核细胞表现出促炎和动脉粥样硬化形成的活性。
J Immunol. 2011 Feb 1;186(3):1809-15. doi: 10.4049/jimmunol.1001866. Epub 2010 Dec 29.
4
CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease.慢性肾脏病患者中 CD14++CD16+ 单核细胞与心血管结局。
Eur Heart J. 2011 Jan;32(1):84-92. doi: 10.1093/eurheartj/ehq371. Epub 2010 Oct 12.
5
Arterial stiffness in mild-to-moderate CKD.轻度至中度慢性肾脏病中的动脉僵硬度
J Am Soc Nephrol. 2009 Sep;20(9):2044-53. doi: 10.1681/ASN.2009010074. Epub 2009 Jul 16.
6
Genetic diversity of CX3CR1 gene and coronary artery disease: new insights through a meta-analysis.CX3CR1 基因的遗传多样性与冠状动脉疾病:通过荟萃分析获得的新见解。
Atherosclerosis. 2009 Nov;207(1):8-15. doi: 10.1016/j.atherosclerosis.2009.03.044. Epub 2009 Apr 5.
7
Blood monocytes: development, heterogeneity, and relationship with dendritic cells.血液单核细胞:发育、异质性及其与树突状细胞的关系
Annu Rev Immunol. 2009;27:669-92. doi: 10.1146/annurev.immunol.021908.132557.
8
Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.血清25-羟维生素D和1,25-二羟维生素D水平低与全因死亡率和心血管死亡率的独立关联。
Arch Intern Med. 2008 Jun 23;168(12):1340-9. doi: 10.1001/archinte.168.12.1340.
9
CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients.CD14(++)CD16+单核细胞而非单核细胞总数可预测透析患者的心血管事件。
Kidney Int. 2008 Mar;73(5):622-9. doi: 10.1038/sj.ki.5002744. Epub 2007 Dec 26.
10
Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey.美国心血管危险因素的患病率及血清25-羟基维生素D水平:第三次全国健康与营养检查调查的数据
Arch Intern Med. 2007 Jun 11;167(11):1159-65. doi: 10.1001/archinte.167.11.1159.